Advancing ethical cosmetics through regulatory excellence

As global chemical regulations continue to evolve, including EU Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and the EU Cosmetics Regulation (CPR), Innospec continues to be at the forefront of delivering compliant, science-led solutions for the personal care industry.

The company’s award-winning approach focuses on deploying New Approach Methodologies (NAMs) and Next Generation Risk Assessments (NGRAs) to support human-relevant safety assessment of cosmetic ingredients across their entire lifecycle, covering occupational, professional and consumer exposure, without the need for animal testing. This approach is becoming increasingly important as beauty brands seek to address regulatory requirements and consumer expectations to responsible product safety and ethical product development.

By aligning regulatory compliance with advances in scientific safety innovation, Innospec helps its customers meet legal obligations while supporting increasing  consumer expectations for ethical products.

Leading innovation in non-animal testing for cosmetic ingredients

A key driver of this recognition is Innospec’s work to reduce reliance on animal testing in cosmetic ingredient safety assessments. Through collaboration with global industry partners and regulatory stakeholders, the company is helping to shape the development and adoption of scientifically robust animal-free cosmetic testing.

Its scientific and regulatory teams are actively advancing alternative methodologies  that aim to deliver human-relevant safety outcomes, while supporting the transition to cruelty-free cosmetic ingredients across global markets.

“Advancing non-animal testing approaches is essential to delivering both regulatory compliance and more human-relevant safety outcomes. At Innospec, we are committed to developing scientifically robust methods that support innovation while meeting the highest standards of safety, ethics, and responsibility. We engage and influence stakeholders, including regulatory agencies, policy makers, and the wider industry, to drive meaningful change.” Jay Dawick, Senior Toxicology and Risk Assessment Manager.

This work reflects Innospec’s broader commitment to delivering high-performing innovative ingredients with improved ethical and environmental impacts.

Supporting customers with compliant ingredient solutions

Innospec’s global regulatory and toxicology teams play a critical role in helping customers navigate the complex regulatory landscape for cosmetic ingredients.

By providing clear safety data, transparent communication, and regulatory expertise, Innospec supports customers in developing products that are compliant with applicable regulations and aligned with their brand values.

The company’s expertise in chemical compliance, combined with active participation in leading industry bodies, helps it remain ahead of regulatory developments while supporting innovation across the sector.

Delivering impact: innovation, compliance, and ethics

Winning the CBIA award for Regulatory & Compliance Excellence highlights Innospec’s ability to combine:

• Regulatory expertise in global cosmetic legislation, including EU REACH and EU CPR
• Innovation in non-animal testing and safety science
• Support for customer ethical and compliance objectives

Together, these capabilities demonstrate how Innospec is helping customers navigate an evolving regulatory environment while supporting the development of safe, compliant and responsibly formulated products.

Learn more about our work to challenge animal testing: https://innospecsustainability.com/social/global-product-safety/challenging-animal-testing/: Innospec Wins 2026 Cosmetics Business Innovation Award for Regulatory Excellence
Learn more about the sustainability of our personal care ingredients range: https://innospecsustainability.com/economic/personal-care/: Innospec Wins 2026 Cosmetics Business Innovation Award for Regulatory Excellence